Pharma Industrial India - Professional magazine for pharma industry suppliers and lab technology

NEWS ABOUT >

Biotechnology

Clean Rooms

Clinical Trials

Consultants

Digitalization

Drug Discovery & Development

Engineering

Global Pharma

Industrial talks

Ingredients

Lab Equipment

Logistics & Distribution

Manufacturing

Market

Outsourcing

Packaging

Quality / GMP

Regulation

Safety

Last edition

All magazines
Subscribe to our magazine

News about "Lupus treatment"

Johnson & Johnson's Nipocalimab Shows Sustained Disease Reduction in Lupus Phase 2 Study

The monoclonal antibody met its primary endpoint in the JASMINE trial and demonstrated continued improvements in disease activity through 52 weeks in adults with moderate-to-severe systemic lupus erythematosus.

Lupus Treatment | 04/06/2026 | By News Bureau

Lupus Research Alliance and Genentech Launch Global Research Programme on Immune Reset Therapies for Lupus

The Lupus Research Alliance and Genentech announce inaugural recipients of the Immune Resetting Therapies for Lupus Award to accelerate research into CAR-T cell therapies for severe lupus patients.

Lupus Treatment | 28/05/2026 | By News Bureau | 108

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members